Skip to main content

Table 11 Cost-effectiveness analysis (CEA) outcomes for mixed wound types (n = 3)

From: A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types

CEA (Original year of values) Treatment vs. Comparator ICER summary/estimate [2013 US$] Unit of effectiveness Incremental cost [2013 US$] Incremental effectiveness
Bale 1998 (1994) [78] Hydrocellular (Allevyn) dressing vs. hydrocolloid (Granuflex) dressing 26 Additional wound healed 3 0.13
Terry 2009 (2008) [79] Telemedicine plus WCS consults vs. WCS consults only Dominateda Additional wound healed 2,085 −0.249
Vu 2007 (2000) [80] Multidisciplinary wound care team vs. UC Dominantb Additional wound healed −346 0.092
  1. ICER, Incremental cost-effectiveness ratio; UC, Usual care; US$, United States dollars; WCS, Wound care specialist.
  2. a“Disproportionate distribution, by chance, in group A [telemedicine plus WCS consults] of large non-healing surgical wounds and large, numerous pressure ulcers”.
  3. bDenotes the higher quality study (Drummond score ≥8).